March 16, 2026 · Form 4 insider transaction
Agarwal Arjun sold 395 shares of ORKA at $41.30 per share, a transaction worth $16.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
The reported sales were effected pursuant to Oruka Therapeutics, Inc.'s automatic, non-discretionary, sell-to-cover procedure to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units.